An in vivo ultrahigh field 14.1 T (1) H-MRS study on 6-OHDA and α-synuclein-based rat models of Parkinson's disease: GABA as an early disease marker.
about
Preclinical Magnetic Resonance Imaging and Spectroscopy Studies of Memory, Aging, and Cognitive DeclineExposure of C. elegans eggs to a glyphosate-containing herbicide leads to abnormal neuronal morphologyQuantification in magnetic resonance spectroscopy based on semi-parametric approaches.Neurometabolic profiles of the substantia nigra and striatum of MPTP-intoxicated common marmosets: An in vivo proton MRS study at 9.4 T.Assessment of brain metabolite correlates of adeno-associated virus-mediated over-expression of human alpha-synuclein in cortical neurons by in vivo (1) H-MR spectroscopy at 9.4 T.Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats.Progressive brain metabolic changes under deep brain stimulation of subthalamic nucleus in parkinsonian rats.In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment.Chronic exposure to a glyphosate-containing pesticide leads to mitochondrial dysfunction and increased reactive oxygen species production in Caenorhabditis elegans.Effects of electroacupuncture on metabolic changes in motor cortex and striatum of 6-hydroxydopamine-induced Parkinsonian rats.Optimized MEGA-SPECIAL for in vivo glutamine detection in the rat brain at 14.1 T.Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats.Examining alterations in GABA concentrations in the basal ganglia of patients with Parkinson's disease using MEGA-PRESS MRS.
P2860
Q26741139-B72C609A-1B7A-478E-8AD5-30026F017E2DQ36945461-CB12C0F9-D53F-4EF2-A7E1-04E4D9428B76Q38124689-5DAB3B32-2EBC-4854-8B8F-1D98956B91F2Q39060890-1FE876BD-8DD2-4497-8F33-332038A57312Q40061455-089413A4-A91E-4075-B325-E23FE99BC008Q40313187-7DAA344F-0436-402B-A6AC-8B25322B50B6Q41657488-CA73BEE9-55B9-406F-837F-BEB09EE3938EQ43549901-92A1AD84-7809-49CC-8725-BDB95BD53C1DQ46251038-4254080F-AB14-4BE9-886B-61CA9D111585Q48029943-66F31D48-4D27-45C0-882E-F2E8FB280DE1Q48632977-4F8B50F5-2491-4B61-961C-AABF5E300C1BQ48793040-AE2A654F-77A0-467C-B9F9-B0FA4B86E8A5Q49564370-2E3FDBAF-CC49-47E5-99AF-4FFD823959D3
P2860
An in vivo ultrahigh field 14.1 T (1) H-MRS study on 6-OHDA and α-synuclein-based rat models of Parkinson's disease: GABA as an early disease marker.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
An in vivo ultrahigh field 14. ...... BA as an early disease marker.
@en
An in vivo ultrahigh field 14.1 T
@nl
type
label
An in vivo ultrahigh field 14. ...... BA as an early disease marker.
@en
An in vivo ultrahigh field 14.1 T
@nl
prefLabel
An in vivo ultrahigh field 14. ...... BA as an early disease marker.
@en
An in vivo ultrahigh field 14.1 T
@nl
P2093
P2860
P356
P1433
P1476
An in vivo ultrahigh field 14. ...... BA as an early disease marker.
@en
P2093
M Craveiro
M N Gaugler
P Aebischer
V Mlynárik
P2860
P356
10.1002/NBM.2817
P577
2012-06-18T00:00:00Z